Cellis is a biotechnology company developing macrophage-based cancer therapy for the treatment of solid tumors.

We specialize in innovative cell-based oncology approaches, with a focus on overcoming resistance in difficult-to-treat cancers.

Our proprietary platform, Macrophage Drug Conjugate (MDC), is based on the TRAIN mechanism, enabling targeted delivery of active compounds directly into the cytoplasm of cancer cells. This results in tumor cell death while simultaneously reshaping the tumor microenvironment to enhance anti-cancer immune responses.

Cellis is advancing its pipeline toward first-in-human clinical trials, while building a strong intellectual property portfolio supported by PCT patent applications and ongoing filings.

Cellis

The office likely focuses on leadership and research in medicinal chemistry and related fields.

gen. Józefa Zajączka

The Gubelstrasse office likely focuses on scientific research and innovation in the pharmaceutical or tech industries.

Gubelstrasse

Robert Aleksandrowicz

This department drives overall organizational strategy and decision-making.

Cellis

Org chart

Teams

Executive Leadership

Offices

Cellis

Org chart

Teams

Executive Leadership

Offices

Related companies